CWNM .128 on radar lock for today! New is out!
Crown Marketing (OTCQB: CWNM) is pleased to announce that Patents for its Controlled Drug Delivery Technology have been approved and registered in South Africa. Crown is continuing to secure its worldwide patent rights as it pursues novel applications of its drug delivery technology
About The Company:
Crown's Controlled Drug Delivery Technology (CDDT) is a novel controlled-release technology, harnessing the principles of diffusion through precise mathematical formulas. The spectrum and reliability of pharmacokinetic profiles achievable with this technology is superior to currently marketed formulations. CDDT's simple design allows for a high level of flexibility in matching chronotherapeutic requirements. Cost-efficiencies in the commercial manufacturing process, when compared to other drug delivery technologies, may constitute its most important competitive advantage.
Market Data 
Markets 
AI
